Supporting Quipt patients at every step
You care about your patients and know that their active engagement in therapy is an important component to success. Resmed myAir™* can help your patients build positive habits as they start therapy and work toward compliance.
Building positive habits from the start
The Personal Therapy Assistant† feature of myAir offers interactive, voice-guided instructions and videos to walk patients through equipment setup.
For virtual setups, have your patients download myAir and follow the setup prompts before their appointment. Then, you can use the time live with your patient to discuss details of their therapy and answer any questions they have.
For in-person setups, you can feel confident that Personal Therapy Assistant will be available to patients when they get home for any additional help they may want to complete setup.
What would a 2% increase in compliance mean to you?
During the first 30 days of therapy, Care Check-In† asks time-based questions appropriate to your patient’s needs. With their consent, you can see their responses in AirView and target outreach to help keep them going with therapy and reach compliance.‡
Designed to motivate and engage patients with therapy, myAir lets them view goals and track their progress, earning badges as they reach key milestones.
Check out this infographic for more detail on how myAir may help patients reach compliance.
Focused on engaging patients
With a broad set of resources to keep patients motivated and provide answers to basic questions, myAir is designed to help patients through their PAP therapy journey.
Get more details about myAir features and how they can help you work more efficiently and support your patients.
* The myAir by Resmed app is available in English and Spanish in the US and in English and French in Canada.
** Coaching entails personalized feedback to encourage continuation of therapy. This is not a healthcare service and is not performed by licensed healthcare providers. Patients are encouraged to speak with their treating clinicians for any clinical symptoms or medical conditions.
† Some features of myAir are only available in the myAir app and with Air11 devices.
‡ Patient consent required to share Care Check-In data.
References
- Resmed survey of clinicians and new and experienced patients who were asked to set up the AirSense 11 device. AirSense 11 is part of the Air11 platform. Survey conducted in Australia, August 17, 2020 – August 21, 2020. n=23.
- Internal Resmed a/b beta test of new patients using a Resmed AirSense 10 or AirSense 11 device and the myAir app. Compliance defined as per the US CMS guidelines: PAP use for ≥ 4 h per night on at least 70% of nights during a consecutive 30-day period during the first 90 days of initial usage. Test conducted between May 24 – September 5, 2023. n =12,600 (Control = 6,300).
- Resmed market research survey results of US Clinicians. Survey conducted August-September 2021. n=95.
- Resmed online survey with US patients who were on AirSense 11 PAP therapy. Survey conducted August 2021-September 2021. n=166.